{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:16:28Z","timestamp":1793722588192,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Sci Food"],"DOI":"10.1038\/s41538-025-00378-y","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T21:51:06Z","timestamp":1738619466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Network pharmacology study on the mechanism of berberine in Alzheimer\u2019s disease model"],"prefix":"10.1038","volume":"9","author":[{"given":"Yaoyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3393-4497","authenticated-orcid":false,"given":"En","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"378_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 397, 1577\u20131590 (2021).","journal-title":"Lancet"},{"key":"378_CR2","doi-asserted-by":"publisher","first-page":"e100751","DOI":"10.1136\/gpsych-2022-100751","volume":"35","author":"R Ren","year":"2022","unstructured":"Ren, R. et al. The China Alzheimer report 2022. Gen. Psychiatr. 35, e100751 (2022).","journal-title":"Gen. Psychiatr."},{"key":"378_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Prim. 7, 33 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"378_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat. Rev. Neurol. 17, 157\u2013172 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"378_CR5","doi-asserted-by":"publisher","first-page":"113933","DOI":"10.1016\/j.biopha.2022.113933","volume":"157","author":"H Hou","year":"2023","unstructured":"Hou, H. et al. Applications and research progress of Traditional Chinese medicine delivered via nasal administration. Biomed. Pharmacother. 157, 113933 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"378_CR6","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.2147\/DDDT.S380612","volume":"17","author":"H Yan","year":"2023","unstructured":"Yan, H., Feng, L. & Li, M. The role of Traditional Chinese Medicine Natural Products in beta-amyloid deposition and tau protein hyperphosphorylation in Alzheimer\u2019s disease. Drug Des. Devel. Ther. 17, 3295\u20133323 (2023).","journal-title":"Drug Des. Devel. Ther."},{"key":"378_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/1567205014666170829102135","volume":"15","author":"K Zeng","year":"2018","unstructured":"Zeng, K. et al. Ginkgo biloba extract EGb761 attenuates hyperhomocysteinemia-induced AD like tau hyperphosphorylation and cognitive impairment in rats. Curr. Alzheimer Res. 15, 89\u201399 (2018).","journal-title":"Curr. Alzheimer Res."},{"key":"378_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.phrs.2017.11.018","volume":"129","author":"F Maione","year":"2018","unstructured":"Maione, F. et al. Downregulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer\u2019s disease. Pharm. Res. 129, 482\u2013490 (2018).","journal-title":"Pharm. Res."},{"key":"378_CR9","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.2147\/NDT.S117469","volume":"12","author":"L Zhou","year":"2016","unstructured":"Zhou, L. et al. Baicalein improves behavioral dysfunction induced by Alzheimer\u2019s disease in rats. Neuropsychiatr. Dis. Treat. 12, 3145\u20133152 (2016).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"378_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13936","volume":"45","author":"M Akbar","year":"2021","unstructured":"Akbar, M. et al. Neuroprotective potential of berberine in modulating Alzheimer\u2019s disease via multiple signaling pathways. J. Food Biochem. 45, e13936 (2021).","journal-title":"J. Food Biochem."},{"key":"378_CR11","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/ptr.5475","volume":"29","author":"C Chen","year":"2015","unstructured":"Chen, C. et al. A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable Bowel syndrome. Phytother. Res. 29, 1822\u20131827 (2015).","journal-title":"Phytother. Res."},{"key":"378_CR12","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.7150\/thno.30787","volume":"9","author":"X Feng","year":"2019","unstructured":"Feng, X. et al. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics 9, 1923\u20131951 (2019).","journal-title":"Theranostics"},{"key":"378_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2174\/1570159X16666180419141613","volume":"17","author":"D Fan","year":"2019","unstructured":"Fan, D. et al. Combating neurodegenerative diseases with the plant alkaloid berberine: molecular mechanisms and therapeutic potential. Curr. Neuropharmacol. 17, 563\u2013579 (2019).","journal-title":"Curr. Neuropharmacol."},{"key":"378_CR14","doi-asserted-by":"publisher","first-page":"1287750","DOI":"10.3389\/fphar.2023.1287750","volume":"14","author":"L Dan","year":"2023","unstructured":"Dan, L. et al. Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer\u2019s disease: a systematic review and meta-analysis. Front Pharm. 14, 1287750 (2023).","journal-title":"Front Pharm."},{"key":"378_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3233\/JAD-200995","volume":"79","author":"YY Wang","year":"2021","unstructured":"Wang, Y. Y. et al. Ameliorating ribosylation-induced amyloid-beta pathology by berberine via inhibiting mTOR\/p70S6K signaling. J. Alzheimers Dis. 79, 833\u2013844 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"378_CR16","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1021\/acschemneuro.0c00808","volume":"12","author":"Y Liang","year":"2021","unstructured":"Liang, Y. et al. Berberine improves behavioral and cognitive deficits in a mouse model of Alzheimer\u2019s disease via regulation of beta-amyloid production and endoplasmic reticulum stress. ACS Chem. Neurosci. 12, 1894\u20131904 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"378_CR17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.fct.2017.11.025","volume":"111","author":"HM Hussien","year":"2018","unstructured":"Hussien, H. M. et al. Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer\u2019s-like disease in rats. Food Chem. Toxicol. 111, 432\u2013444 (2018).","journal-title":"Food Chem. Toxicol."},{"key":"378_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.fitote.2016.02.001","volume":"109","author":"CS Liu","year":"2016","unstructured":"Liu, C. S. et al. Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia 109, 274\u2013282 (2016).","journal-title":"Fitoterapia"},{"key":"378_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2012.09.051","volume":"145","author":"W Tao","year":"2013","unstructured":"Tao, W. et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J. Ethnopharmacol. 145, 1\u201310 (2013).","journal-title":"J. Ethnopharmacol."},{"key":"378_CR20","doi-asserted-by":"publisher","first-page":"845591","DOI":"10.3389\/fphar.2022.845591","volume":"13","author":"Z Cheng","year":"2022","unstructured":"Cheng, Z. et al. Berberine: a promising treatment for neurodegenerative diseases. Front Pharm. 13, 845591 (2022).","journal-title":"Front Pharm."},{"key":"378_CR21","doi-asserted-by":"publisher","first-page":"106210","DOI":"10.1016\/j.bioorg.2022.106210","volume":"133","author":"RL Zhang","year":"2023","unstructured":"Zhang, R. L. et al. Protective effects of berberine against beta-amyloid-induced neurotoxicity in HT22 cells via the Nrf2\/HO-1 pathway. Bioorg. Chem. 133, 106210 (2023).","journal-title":"Bioorg. Chem."},{"key":"378_CR22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00213-018-5090-6","volume":"236","author":"JS de Oliveira","year":"2019","unstructured":"de Oliveira, J. S. et al. Neuroprotective effects of berberine on recognition memory impairment, oxidative stress, and damage to the purinergic system in rats submitted to intracerebroventricular injection of streptozotocin. Psychopharmacology 236, 641\u2013655 (2019).","journal-title":"Psychopharmacology"},{"key":"378_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11011-018-0349-5","volume":"34","author":"S Sadraie","year":"2019","unstructured":"Sadraie, S. et al. Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms. Metab. Brain Dis. 34, 245\u2013255 (2019).","journal-title":"Metab. Brain Dis."},{"key":"378_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41551-021-00759-0","volume":"6","author":"Y Duan","year":"2022","unstructured":"Duan, Y. et al. Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer\u2019s disease alleviates amyloid-related pathologies in mice. Nat. Biomed. Eng. 6, 168\u2013180 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"378_CR25","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel, H. et al. The amyloid-beta pathway in Alzheimer\u2019s disease. Mol. Psychiatry 26, 5481\u20135503 (2021).","journal-title":"Mol. Psychiatry"},{"key":"378_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran, E. & De Strooper, B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat. Rev. Drug Discov. 21, 306\u2013318 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"378_CR27","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1093\/brain\/awae092","volume":"147","author":"C Hung","year":"2024","unstructured":"Hung, C. et al. APP antisense oligonucleotides reduce Abeta aggregation and rescue endolysosomal dysfunction in Alzheimer\u2019s disease. Brain. 147, 2325\u20132333 (2024).","journal-title":"Brain."},{"key":"378_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10571-017-0554-5","volume":"38","author":"S Villapol","year":"2018","unstructured":"Villapol, S. Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation. Cell Mol. Neurobiol. 38, 121\u2013132 (2018).","journal-title":"Cell Mol. Neurobiol."},{"key":"378_CR29","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu, A. et al. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci. 16, 1347987 (2024).","journal-title":"Front Aging Neurosci."},{"key":"378_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tips.2023.11.004","volume":"45","author":"C Titus","year":"2024","unstructured":"Titus, C., Hoque, M. T. & Bendayan, R. PPAR agonists for the treatment of neuroinflammatory diseases. Trends Pharm. Sci. 45, 9\u201323 (2024).","journal-title":"Trends Pharm. Sci."},{"key":"378_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.intimp.2018.11.044","volume":"66","author":"Q Li","year":"2019","unstructured":"Li, Q. et al. Luteoloside attenuates neuroinflammation in focal cerebral ischemia in rats via regulation of the PPARgamma\/Nrf2\/NF-kappaB signaling pathway. Int. Immunopharmacol. 66, 309\u2013316 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"378_CR32","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.pharep.2015.03.002","volume":"67","author":"T Ahmed","year":"2015","unstructured":"Ahmed, T. et al. Berberine and neurodegeneration: a review of literature. Pharm. Rep. 67, 970\u2013979 (2015).","journal-title":"Pharm. Rep."},{"key":"378_CR33","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W364 (2019).","journal-title":"Nucleic Acids Res."},{"key":"378_CR34","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2021","unstructured":"Davis, A. P. et al. Comparative Toxicogenomics Database (CTD): update 2021. Nucleic Acids Res. 49, D1138\u2013D1143 (2021).","journal-title":"Nucleic Acids Res."},{"key":"378_CR35","doi-asserted-by":"publisher","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","volume":"44","author":"MK Gilson","year":"2016","unstructured":"Gilson, M. K. et al. BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 44, D1045\u2013D1053 (2016).","journal-title":"Nucleic Acids Res."},{"key":"378_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/bioinformatics\/btab733","volume":"38","author":"S Min","year":"2022","unstructured":"Min, S., Lee, B. & Yoon, S. TargetNet: functional microRNA target prediction with deep neural networks. Bioinformatics 38, 671\u2013677 (2022).","journal-title":"Bioinformatics"},{"key":"378_CR37","doi-asserted-by":"publisher","first-page":"116012","DOI":"10.1016\/j.biopha.2023.116012","volume":"170","author":"Y Tang","year":"2024","unstructured":"Tang, Y. et al. Berberine exerts antidepressant effects in vivo and in vitro through the PI3K\/AKT\/CREB\/BDNF signaling pathway. Biomed. Pharmacother. 170, 116012 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"378_CR38","doi-asserted-by":"publisher","unstructured":"Seibenhener, M. L. & Wooten, M. C. Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J. Vis. Exp. e52434 (2015). https:\/\/doi.org\/10.3791\/52434.","DOI":"10.3791\/52434"}],"container-title":["npj Science of Food"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41538-025-00378-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41538-025-00378-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41538-025-00378-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T21:51:10Z","timestamp":1738619470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41538-025-00378-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1038\/s41538-025-00378-y","relation":{},"ISSN":["2396-8370"],"issn-type":[{"value":"2396-8370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}